BDBM391118 US9957264, Example 5-189::US9957264, Example 5-190::{(3S)-3-[3-({4-[(1R or 1S)- 1-(tert-butylamino)-2,2,2- trifluoroethyl]phenyl} amino)-4-oxo-4,5- dihydro-1H-pyrazolo [4,3-c]pyridin-1- yl]tetrahydro-2H-pyran-3- yl}acetonitrile (from I-17B. Derived from Peak A via SFC: IA column, 35% MeOH in CO2, Tr = 2.8 minutes on OBn intermediate)

SMILES CC(C)(C)NC(c1ccc(Nc2nn(c3cc[nH]c(=O)c23)[C@]2(CC#N)CCCOC2)cc1)C(F)(F)F

InChI Key InChIKey=YYKBDXVPRSJIGW-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 391118   

TargetTyrosine-protein kinase JAK1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM391118({(3S)-3-[3-({4-[(1R or 1S)- 1-(tert-butylamino)-2,...)
Affinity DataIC50: 0.140nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM391118({(3S)-3-[3-({4-[(1R or 1S)- 1-(tert-butylamino)-2,...)
Affinity DataIC50: 0.170nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM391118({(3S)-3-[3-({4-[(1R or 1S)- 1-(tert-butylamino)-2,...)
Affinity DataIC50: 0.210nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM391118({(3S)-3-[3-({4-[(1R or 1S)- 1-(tert-butylamino)-2,...)
Affinity DataIC50: 0.380nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent